M Salvador

494 total citations
19 papers, 361 citations indexed

About

M Salvador is a scholar working on Cardiology and Cardiovascular Medicine, General Health Professions and Surgery. According to data from OpenAlex, M Salvador has authored 19 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 2 papers in General Health Professions and 1 paper in Surgery. Recurrent topics in M Salvador's work include Blood Pressure and Hypertension Studies (4 papers), Healthcare Systems and Practices (2 papers) and Cardiovascular Health and Disease Prevention (2 papers). M Salvador is often cited by papers focused on Blood Pressure and Hypertension Studies (4 papers), Healthcare Systems and Practices (2 papers) and Cardiovascular Health and Disease Prevention (2 papers). M Salvador collaborates with scholars based in France, United States and Spain. M Salvador's co-authors include B Chamontin, Jacques Amar, Catherine Arnaud, Vanina Bongard, Isabelle Vernier, R. Aziza, F. Joffre, P Bernadet, Christelle Cantet and J.-P. Cambou and has published in prestigious journals such as Radiology, Kidney International and Journal of Hypertension.

In The Last Decade

M Salvador

15 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Salvador France 5 220 119 115 110 29 19 361
Αντώνιος Καρπέτας Greece 11 374 1.7× 242 2.0× 170 1.5× 64 0.6× 30 1.0× 30 485
Krishnamurti Rao United States 6 363 1.6× 44 0.4× 41 0.4× 149 1.4× 46 1.6× 7 439
Shoji Iwaya Japan 13 237 1.1× 31 0.3× 63 0.5× 156 1.4× 20 0.7× 16 422
Lucas S. Aparicio Argentina 12 337 1.5× 21 0.2× 152 1.3× 35 0.3× 25 0.9× 45 421
Paola Molino Italy 11 118 0.5× 14 0.1× 82 0.7× 74 0.7× 30 1.0× 19 290
Montserrat Carrera Spain 4 72 0.3× 319 2.7× 176 1.5× 39 0.4× 9 0.3× 4 451
Jochen Strauß Germany 6 57 0.3× 45 0.4× 93 0.8× 75 0.7× 8 0.3× 13 210
Dirk Huber Germany 10 166 0.8× 31 0.3× 218 1.9× 51 0.5× 53 1.8× 13 302
Giancarlo Orlandini Germany 5 50 0.2× 375 3.2× 151 1.3× 67 0.6× 22 0.8× 5 436
Alexander J. Kula United States 8 179 0.8× 98 0.8× 33 0.3× 121 1.1× 26 0.9× 22 269

Countries citing papers authored by M Salvador

Since Specialization
Citations

This map shows the geographic impact of M Salvador's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Salvador with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Salvador more than expected).

Fields of papers citing papers by M Salvador

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Salvador. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Salvador. The network helps show where M Salvador may publish in the future.

Co-authorship network of co-authors of M Salvador

This figure shows the co-authorship network connecting the top 25 collaborators of M Salvador. A scholar is included among the top collaborators of M Salvador based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Salvador. M Salvador is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Salvador, M, et al.. (2025). Questioning latency period in causality assessment: On the hepatotoxicity of atorvastatin. Revista Española de Enfermedades Digestivas.
2.
Amar, Jacques, B Chamontin, N Genès, et al.. (2003). Why is hypertension so frequently uncontrolled in secondary prevention?. Journal of Hypertension. 21(6). 1199–1205. 43 indexed citations
3.
Hanaire-Broutin, H, et al.. (2001). [Microalbuminuria, pulse wave velocity and common carotid artery intima-media thickness in type 2 diabetes].. PubMed. 94(8). 795–8. 2 indexed citations
4.
Amar, Jacques, Isabelle Vernier, Vanina Bongard, et al.. (2000). Nocturnal blood pressure and 24-hour pulse pressure are potent indicators of mortality in hemodialysis patients. Kidney International. 57(6). 2485–2491. 175 indexed citations
5.
Chamontin, B, et al.. (2000). [Treatment of arterial hypertension in the diabetic].. PubMed. 29(13). 749–55. 1 indexed citations
6.
Vernier, Isabelle, et al.. (1999). [Influence of absolute risk and sex on the treatment of arterial hypertension in Haute-Garonne].. PubMed. 92(8). 945–8. 1 indexed citations
7.
Bousquet, Elodie, Jacques Amar, M Salvador, & B Chamontin. (1999). [Cataract and simvastatin: case report].. PubMed. 53(5). 505–7. 4 indexed citations
8.
Berdah, Jean François, et al.. (1998). [Study of the efficacy and safety of fosinopril in general practice in 19,435 hypertensive patients (FLIGHT Study)].. PubMed. 47(3). 169–75. 3 indexed citations
9.
Ruíz, Ignacio Montero, et al.. (1998). Validación de la Escala de Riesgo de Violencia de Plutchik en población española. Dialnet (Universidad de la Rioja). 61(4). 307–316. 8 indexed citations
10.
Chamontin, B, et al.. (1996). Dippers and non-dippers among overweight hypertensive men.. PubMed. 1(4). 329–332. 9 indexed citations
11.
Conti, Paulo César Rodrigues, et al.. (1996). Disfuncao craniomandibular (dcm) - parte ii- aspectos psicologicos e hiperatividade muscular. 4(2). 3 indexed citations
12.
Joffre, F., et al.. (1994). Renal artery stent placement: long-term results with the Wallstent endoprosthesis.. Radiology. 191(3). 713–719. 101 indexed citations
13.
Chamontin, B, et al.. (1992). [For which hypertensive patient should angiotensin-converting enzyme inhibitor be prescribed or forbidden?].. PubMed. 42(20). 2545–9. 1 indexed citations
14.
Caron, P., et al.. (1992). [Acromegaly and bronchial carcinoid tumor. Apropos of a case].. PubMed. 53(4). 158–61. 4 indexed citations
15.
Salvador, M, et al.. (1990). [Outcome of "white coat reaction" induced by nurse and physician in patients with hypertension treated with a beta blockader (bisoprolol)].. PubMed. 83(8). 1115–8. 1 indexed citations
16.
Chamontin, B, et al.. (1985). Anglotensin Converting Enzyme Inhibitor, Diuretic, and Calcium Antagonist. Journal of Hypertension. 3(5). 548–548. 1 indexed citations
17.
Chamontin, B, et al.. (1981). [Competitive inhibitors of angiotensin II].. PubMed. 35(5). 637–40.
18.
Salvador, M, et al.. (1971). [Prevention of rhythm disorders by a new quinidine salt with sustained-action: study of quinidinemia (apropos of 45 cases)].. PubMed. 64(5). 712–26. 2 indexed citations
19.
Dardenne, P, Miquel Pujol, & M Salvador. (1960). [Significance of retinal arterial pressure in the treatment of hypertension].. PubMed. 15. 878–81. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026